OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The impact of E3 ligase choice on PROTAC effectiveness in protein kinase degradation
Tomasz Sobierajski, Joanna Małolepsza, Marta Pichlak, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104032-104032
Open Access | Times Cited: 9
Tomasz Sobierajski, Joanna Małolepsza, Marta Pichlak, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104032-104032
Open Access | Times Cited: 9
Showing 9 citing articles:
Discovery of novel benzosultam CRBN ligands
Hoyeong Park, Santosh Shivanand Raikar, Yonghyo Kim, et al.
Bulletin of the Korean Chemical Society (2025)
Closed Access
Hoyeong Park, Santosh Shivanand Raikar, Yonghyo Kim, et al.
Bulletin of the Korean Chemical Society (2025)
Closed Access
Cutting-edge biotherapeutics and advanced delivery strategies for the treatment of metabolic dysfunction-associated steatotic liver disease spectrum
Juhyeong Hong, Yong‐Hee Kim
Journal of Controlled Release (2025) Vol. 380, pp. 433-456
Closed Access
Juhyeong Hong, Yong‐Hee Kim
Journal of Controlled Release (2025) Vol. 380, pp. 433-456
Closed Access
In silico modeling of targeted protein degradation
Wenxing Lv, Xiaojuan Jia, Bowen Tang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117432-117432
Open Access
Wenxing Lv, Xiaojuan Jia, Bowen Tang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117432-117432
Open Access
Design and optimization strategies of PROTACs and its Application, Comparisons to other targeted protein degradation for multiple oncology therapies
M. Malarvannan, S. Unnikrishnan, S. Monohar, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107984-107984
Closed Access | Times Cited: 1
M. Malarvannan, S. Unnikrishnan, S. Monohar, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107984-107984
Closed Access | Times Cited: 1
Discovery of the First Selective and Potent PROTAC Degrader for the Pseudokinase TRIB2
Chaowei Wen, Prathibha R. Gajjala, Yihan Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117016-117016
Closed Access
Chaowei Wen, Prathibha R. Gajjala, Yihan Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117016-117016
Closed Access
PROTACs of cyclin-dependent kinases
Denisa Veselá, Eva Řezníčková, Václav Mik, et al.
Annual reports in medicinal chemistry (2024)
Closed Access
Denisa Veselá, Eva Řezníčková, Václav Mik, et al.
Annual reports in medicinal chemistry (2024)
Closed Access
Protacs in cancer therapy: mechanisms, design, clinical trials, and future directions
Akash Vikal, Rashmi Maurya, Brij Bihari Patel, et al.
Drug Delivery and Translational Research (2024)
Closed Access
Akash Vikal, Rashmi Maurya, Brij Bihari Patel, et al.
Drug Delivery and Translational Research (2024)
Closed Access
Development of PROTACs targeting estrogen receptor: An emerging technique for combating endocrine resistance
Rouming Peng, Xin Liu, Chun‐Chi Chen, et al.
RSC Medicinal Chemistry (2024)
Closed Access
Rouming Peng, Xin Liu, Chun‐Chi Chen, et al.
RSC Medicinal Chemistry (2024)
Closed Access
CRBN‐PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications
Riya Thapa, Asif Ahmad Bhat, Gaurav Gupta, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 5
Open Access
Riya Thapa, Asif Ahmad Bhat, Gaurav Gupta, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 5
Open Access
